R

Director Director DIN 07685099
DIN 07685099 First appointment Dec 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2016
Shareholding value •••• Premium profile

About Revathi

Data last updated:

Revathi was a Director at Ttd Pharma Private Limited (2022–2023) and Director at Nopel Technologies Private Limited (2016–2018). The companies operate in Chemicals and Information Technology.

DIN 07685099
Primary Designation Director
Industry Chemicals
First Appointment 30 Dec 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ttd Pharma Private Limited U24290AP2022PTC122080
Director24 Jun 20222022Active
Nopel Technologies Private Limited U72100TG2016PTC112566
Director30 Dec 20162016₹8.1 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ttd Pharma Private Limited
Nopel Technologies Private Limited
Premium access

Shareholding and investment profile for Revathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Revathi

Revathi was first appointed on 30 Dec 2016 as Director at Nopel Technologies Private Limited. The most recent appointment on record is 24 Jun 2022 at Ttd Pharma Private Limited.

Revathi held 2 earlier board appointments: Ttd Pharma Private Limited (Director, 24 Jun 2022 to 30 Dec 2023); Nopel Technologies Private Limited (Director, 30 Dec 2016 to 31 May 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available